Laine Thomas Selected Research

Nateglinide (Starlix)

1/2018	Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.
5/2017	Updated risk factors should be used to predict development of diabetes.
4/2017	Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
3/2015	Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial.
12/2013	Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
11/2013	Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
6/2013	Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
3/2013	Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laine Thomas Research Topics

Disease

49	Atrial Fibrillation 01/2022 - 11/2012
41	Stroke (Strokes) 01/2022 - 04/2012
34	Hemorrhage 01/2022 - 04/2012
20	Heart Failure 01/2022 - 03/2013
20	Myocardial Infarction 12/2019 - 04/2011
14	ST Elevation Myocardial Infarction 03/2021 - 01/2012
13	Embolism (Embolus) 01/2019 - 11/2012
8	Glucose Intolerance 01/2018 - 03/2013
7	Non-ST Elevated Myocardial Infarction 03/2021 - 04/2012
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 11/2013
6	Hypertension (High Blood Pressure) 01/2016 - 07/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 03/2016 - 07/2013
4	Ischemic Stroke 01/2021 - 05/2015
4	Thrombosis (Thrombus) 01/2020 - 09/2013
4	Leiomyoma (Uterine Fibroids) 01/2020 - 01/2018
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017 - 03/2014
3	Acute Coronary Syndrome 01/2022 - 12/2012
3	Transient Ischemic Attack 01/2022 - 05/2014
3	Chronic Renal Insufficiency 09/2021 - 11/2012
3	Peripheral Arterial Disease 01/2021 - 01/2016
3	Frailty 01/2019 - 07/2013
3	Unstable Angina 01/2019 - 05/2012
2	Neoplasms (Cancer) 12/2017 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2016 - 07/2013
2	Cardiogenic Shock 06/2015 - 08/2013
2	Heart Diseases (Heart Disease) 05/2015 - 02/2015
2	Diabetes Mellitus 08/2014 - 07/2013
2	Body Weight (Weight, Body) 07/2014 - 11/2013
1	Thromboembolism 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Pain (Aches) 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Cognitive Dysfunction 01/2019
1	Torsades de Pointes (Torsade de Pointes) 01/2018
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2017

Drug/Important Bio-Agent (IBA)

31	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2012
22	apixabanIBA 01/2022 - 11/2012
13	AnticoagulantsIBA 01/2022 - 05/2012
9	Vitamin K FDA Link 01/2022 - 09/2013
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2012
8	Valsartan (Vals)FDA Link 01/2018 - 03/2013
8	Nateglinide (Starlix)FDA LinkGeneric 01/2018 - 03/2013
7	Pharmaceutical PreparationsIBA 01/2018 - 04/2014
6	Neprilysin (Neutral Endopeptidase)IBA 01/2021 - 12/2018
6	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2018
5	Dabigatran FDA Link 01/2021 - 11/2013
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2018
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 12/2018
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019 - 07/2013
4	CreatinineIBA 09/2021 - 03/2013
4	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 01/2018
4	Anti-Arrhythmia AgentsIBA 01/2020 - 07/2013
4	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 10/2014
4	N(4)-oleylcytosine arabinosideIBA 01/2018 - 12/2016
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2019
3	RivaroxabanIBA 01/2021 - 01/2016
3	Hemoglobins (Hemoglobin)IBA 03/2017 - 04/2011
3	Clopidogrel (Plavix)FDA Link 03/2016 - 04/2012
3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 11/2013
2	PotassiumIBA 04/2017 - 06/2013
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2015 - 11/2013
2	Dronedarone FDA Link 05/2015 - 02/2015
2	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 05/2015 - 02/2015
2	Glycoproteins (Glycoprotein)IBA 12/2012 - 05/2012
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Enalapril FDA LinkGeneric 12/2020
1	Factor Xa InhibitorsIBA 01/2020
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2019
1	NitratesIBA 12/2019
1	AngiotensinsIBA 11/2019
1	dofetilide (Tikosyn)FDA Link 01/2018
1	Digoxin (Digitek)FDA LinkGeneric 01/2018
1	CholesterolIBA 01/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2018
1	LipidsIBA 01/2018
1	A 19IBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Progestins (Progestagens)IBA 01/2018

Therapy/Procedure

40	Therapeutics 01/2022 - 04/2013
13	Percutaneous Coronary Intervention 01/2022 - 05/2012
4	Uterine Myomectomy 01/2020 - 01/2018
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 04/2013
4	Patient Readmission 06/2015 - 01/2012
3	Hysterectomy 01/2020 - 01/2018
3	Stents 01/2020 - 11/2013
2	Contraindications 01/2022 - 01/2019
2	Secondary Prevention 10/2019 - 07/2013
2	Cardiac Resynchronization Therapy 01/2018 - 04/2013
2	Patient Transfer (Patient Dumping) 03/2016 - 06/2015
2	Cardiac Rehabilitation 11/2015 - 06/2014
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2015 - 05/2013
1	Drug Therapy (Chemotherapy) 12/2020
1	Endometrial Ablation Techniques 01/2018
1	Uterine Artery Embolization 01/2018
1	Intrauterine Devices (Intrauterine Device) 01/2018
1	Time-to-Treatment 01/2018
1	Drug Tapering 01/2018
1	Surgical Instruments (Clip) 12/2017